Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)

DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, today confirmed that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug ... Biopharmaceuticals, Generics, FDA, Product LaunchAllergan, CRESTOR, rosuvastatin, AstraZeneca
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news